SPDR UK All Sh Accum.Shs GBP (GB:FTAL) Price & Chart
GB:FTAL ETF Chart & Stats
£9,301.00
At close: 4:00 PM EST- Day’s Range
- GBP 9,174.00 - GBP 9,303.00
- 52-Week Range
- GBP 7,894.05 - GBP 9,545.00
- Previous Close
- GBP 9,395.00
- Volume
- 3,971
- Average Volume (3M)
- 5,228
- AUM
- 395.72M
- NAV
- 93.90
- Expense Ratio
- 0.20%
- Holdings Count
- 496
- Beta
- 1.00
- Inception Date
- Feb 28, 2012
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 4,193,643
- Standard Deviation
- N/A
ETF Overview
SPDR UK All Sh Accum.Shs GBP
The SPDR UK All Sh Accum.Shs GBP, trading under the ticker GB:FTAL, is an innovative exchange-traded fund (ETF) designed to provide investors with comprehensive exposure to the UK equities market. This ETF falls under the 'Size and Style' category, specifically targeting the 'Total Market' segment within a broad-based niche. It offers a unique opportunity for investors seeking to capture the full spectrum of the UK stock market, encompassing a diverse range of sectors and capitalization sizes. By focusing on the total market, the SPDR UK All Sh Accum.Shs GBP aims to replicate the performance of the entire UK equity landscape, providing a balanced mix of growth and value stocks across large, mid, and small-cap companies. This approach ensures investors can benefit from the collective growth potential of the UK's dynamic and evolving market. The accumulation shares aspect of the fund means that any dividends are automatically reinvested, enhancing the potential for capital appreciation over the long term. Ideal for investors seeking broad-market exposure with the convenience and liquidity of an ETF, GB:FTAL offers a strategic vehicle for those looking to diversify their portfolio while gaining access to the economic heartbeat of the United Kingdom. Whether you're an individual investor seeking to capitalize on the UK's market dynamics or an institutional player aiming for comprehensive market coverage, the SPDR UK All Sh Accum.Shs GBP stands out as a robust and efficient investment choice.
- Asset Class
- Equity
- Region
- Europe
- Issuer
- SPDR
- Index Tracked
- FTSE All-Share
- Ticker Symbol
- GB:FTAL
GB:FTAL ETF News
AstraZeneca Advances New Ovarian Cancer Combination Study
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s TREVI-OC-02 study is testing torvutatug samrotecan with bevacizumab as first-line maintenance treatment for advanced ovarian, fallopian
1d agoAZN
AstraZeneca Advances China Cancer Trial as Durvalumab Takes Center Stage
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s Phase 3 MATTERHORN-CN study is testing treatment for Chinese patients with operable gastric and gastroesophageal junction
1d agoAZN
GB:FTAL ETF FAQ
What was GB:FTAL’s price range in the past 12 months?
GB:FTAL’s lowest price in the past 12 months was GBP 7,894.05 and its highest was GBP 9,545.00.
What is the AUM of GB:FTAL?
As of Nov 05, 2026, the AUM of GB:FTAL is £395.72M.
Is GB:FTAL overvalued?
Based on Wall Street analyst price targets for GB:FTAL’s holdings, GB:FTAL’s price is currently undervalued.
How many shares outstanding does GB:FTAL have?
GB:FTAL has 4,193,643 shares outstanding.
GB:FTAL ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| HSBAHsbc Holdings Plc (UK) | 7.70% |
| SHELShell plc (UK) | 7.59% |
| AZNAstraZeneca plc | 7.24% |
| ULVRUnilever Plc (UK) | 3.60% |
| RRRolls-Royce Holdings | 3.57% |
| BATSBritish American Tobacco (UK) | 3.29% |
| BPBP p.l.c. | 3.06% |
| GSKGlaxoSmithKline plc (UK) | 2.59% |
| RIORio Tinto (LSE:RIO) | 2.23% |
| NGNational Grid (Uk) | 2.21% |
| Total | 43.10% |
